Background: There is evidence of musculoskeletal and respiratory involvement in patients with chronic kidney disease (CKD). This is attributed to protein calorie imbalance that is caused by the disease process, and hemodialysis and is generally referred to as uremic myopathy. This results in calcification of respiratory muscles such as diaphragm and intercostal muscles. There are limited data about respiratory muscle strength in patients with CKD. We intended to evaluate the effect of kidney transplantation on respiratory muscles strength in patients with CKD. Materials and Methods: Spirometry was used to measure maximal inspiratory mouth pressure (PIMAX), which was calculated by using the lung residual volume and maximal respiratory pressures at the mouth (PEMAX), 2 days before and again 30 days after kidney transplantation in 26 patients with ESRD. PIMAX and PEMAX values less than 60% of the predicted value were considered abnormal. Results: Mean ± SD PIMAX values showed significant increase from 31.88 ± 8.58 cmH2O before kidney transplantation to 37.65 ± 13.39 cmH2O after transplant (P < 0.001). Similarly, a significant increase in PEMAX values was observed from 33.04 ± 16.12 cmH2O to 39.19 ± 20.34 cmH2O (P < 0.001). Nineteen patients (73.1%) showed significant increases in PIMAX and PEMAX values. Mean serum creatinine decreased from 6.94 to 1.32 (P < 0.001) after transplant. Conclusion: Although both PIMAX and PEMAX values increased significantly after kidney transplant, these measurements were still below lower limit of normal. This suggests that factors other than uremic myopathy may contribute to respiratory muscle weakness in patients CKD.
INTRODUCTION
Chronic kidney disease not only deteriorates renal function, but also affects other organs, including respiratory system muscles. This, in addition to the effects of hemodialysis, may weaken the respiratory muscles of patients with CKD (1) (2) (3) . In fact, patients with CKD who receive hemodialysis are less active and suffer from muscle weakness and atrophy (4) . This is related to several factors such as anemia, malnutrition, protein-calorie imbalance, decreased serum calcium level, decreased oxidative stress, etc. Uremia exerts its detrimental effects on muscles via intravascular calcification and decreased blood flow.
Respiratory muscles are no exception to these effects (5-7).
Decreased respiratory muscle strength in CKD patients has TANAFFOS been reported in previous studies (8) . It has been shown that longer duration of hemodialysis dependence is associated with decreased strength of respiratory muscles (9) . These changes have been noted clinically and histologically and microscopic evaluation of muscle fibers of patients with CKD has shown structural abnormality and myopathy (3) .
Patients with CKD may suffer some adverse effects related to their myopathy. In addition to decreased quality of life, patients with respiratory muscle myopathy suffer from decreased ventilation, which may result in pleural effusion, dyspnea, and hypoxia (9) . A few small studies have indicated that kidney transplant may significantly improve muscle strength and pulmonary function of patients with CKD (10) (11) (12) (13) (14) .
Those studies (10) (11) (12) (13) (14) reported that kidney transplantation was a successful in improving pulmonary function of uremic patients. However, data on the effects of kidney transplantation on respiratory muscle strength are limited. Of the aforementioned studies only three assessed changes in respiratory muscle strength after kidney transplant (11, 13, 14) . Since survival of CKD patients is increasing with kidney transplantation, it is highly likely for clinicians to face post-kidney transplant patients with complaints about their respiratory function. Therefore, we designed a study to evaluate the effect of kidney transplant on respiratory muscle strength of patients with CKD.
The objective of this study was to compare pre-and post-transplant respiratory muscle strength of patients end stage renal disease (ESRD), who underwent successful kidney transplantation.
MATERIALS AND METHODS
In this cohort study, the population studied consisted of patients aged 15-70 years with ESRD, who were receiving hemodialysis for at least 3 months and were candidates for kidney transplantation. Exclusion criteria included uncontrolled heart disease or arrhythmias, and PEMAX (maximal expiratory pressures, MEP) at the mouth measured by using the total ling capacity (TLC)
were used as indicators of respiratory muscle strength.
Lower limit normal (LLN) for PIMAX in the age range of 20-54 years is 80 cmH2O in males and 55 cmH2O in females.
Lower limit normal for PEMAX are 149 and 98 cmH2O in males and females, respectively. Other laboratory data (blood urea nitrogen, creatinine, sodium, potassium, calcium, phosphorus, and hemoglobin), as well as cyclosporine and corticosteroid dosages administered after transplantation operation were also collected.
Statistical analyses
Descriptive indices including mean and standard deviation (SD), frequency, and percentages were used to report data. Paired t-test was used to compare pre-and post-transplant data. In order to compare PIMAX and PEMAX values between the two groups at two time points (i.e., Table 4 compares laboratory data before and after kidney transplantation between groups 1 and 2. Compared to group 2, patients in group 1 had significantly lower phosphorous levels beforeand higher hemoglobin levels after undergoing kidney transplantation. Table 5 shows hemodialysis duration, serum cyclosporine level, erythropoietin dosage, as well as corticosteroid dosage for both groups. cannot compare all of them. Also, they followed their patients for 90 days (11) while we followed ours for 30 days. It is possible to obtain even higher PIMAX and PEMAX measurements with longer follow-ups. Therefore, it could be a recommended for future studies to design a 
